476 related articles for article (PubMed ID: 11961397)
1. Platelet GPIIb/IIIa is activated and platelet-leukocyte coaggregates formed in vivo during hemodialysis.
Kawabata K; Nakai S; Miwa M; Sugiura T; Otsuka Y; Shinzato T; Hiki Y; Tomimatsu I; Ushida Y; Hosono F; Maeda K
Nephron; 2002 Apr; 90(4):391-400. PubMed ID: 11961397
[TBL] [Abstract][Full Text] [Related]
2. Cilostazol inhibits platelet-leukocyte interaction by suppression of platelet activation.
Ito H; Miyakoda G; Mori T
Platelets; 2004 Aug; 15(5):293-301. PubMed ID: 15370100
[TBL] [Abstract][Full Text] [Related]
3. Platelet-leukocyte aggregates during hemodialysis: effect of membrane type.
Gawaz MP; Mujais SK; Schmidt B; Blumenstein M; Gurland HJ
Artif Organs; 1999 Jan; 23(1):29-36. PubMed ID: 9950176
[TBL] [Abstract][Full Text] [Related]
4. Platelet-leukocyte aggregation during hemodialysis.
Gawaz MP; Mujais SK; Schmidt B; Gurland HJ
Kidney Int; 1994 Aug; 46(2):489-95. PubMed ID: 7526025
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the effects of cellulose triacetate and polysulfone membrane on GPIIb/IIIa and platelet activation.
Kuragano T; Kuno T; Takahashi Y; Yamamoto C; Nagura Y; Takahashi S; Kanmatsuse K
Blood Purif; 2003; 21(2):176-82. PubMed ID: 12601261
[TBL] [Abstract][Full Text] [Related]
6. Effect of glycoprotein IIb/IIIa inhibitors on CD62p expression, platelet aggregates, and microparticles in vitro.
Matzdorff AC; Kühnel G; Kemkes-Matthes B; Pralle H; Voss R; Fareed J
J Lab Clin Med; 2000 Mar; 135(3):247-55. PubMed ID: 10711863
[TBL] [Abstract][Full Text] [Related]
7. Glycoprotein IIb/IIIa inhibition attenuates platelet-activating factor-induced platelet activation by reducing protein kinase C activity.
Hu H; Zhang W; Li N
J Thromb Haemost; 2003 Aug; 1(8):1805-12. PubMed ID: 12911597
[TBL] [Abstract][Full Text] [Related]
8. Sulfatides activate platelets through P-selectin and enhance platelet and platelet-leukocyte aggregation.
Merten M; Beythien C; Gutensohn K; Kühnl P; Meinertz T; Thiagarajan P
Arterioscler Thromb Vasc Biol; 2005 Jan; 25(1):258-63. PubMed ID: 15528476
[TBL] [Abstract][Full Text] [Related]
9. In vitro measurement of platelet glycoprotein IIb/IIIa receptor blockade by abciximab: interindividual variation and increased platelet secretion.
Rossi F; Rossi E; Pareti FI; Colli S; Tremoli E; Gallo L
Haematologica; 2001 Feb; 86(2):192-8. PubMed ID: 11224490
[TBL] [Abstract][Full Text] [Related]
10. Soluble P-selectin is released from activated platelets in vivo during hemodialysis.
Kawabata K; Nagake Y; Shikata K; Fukuda S; Nakazono H; Takahashi M; Ichikawa H; Makino H
Nephron; 1998; 78(2):148-55. PubMed ID: 9496730
[TBL] [Abstract][Full Text] [Related]
11. Different Effects of Ranibizumab and Bevacizumab on Platelet Activation Profile.
Sobolewska B; Grimmel C; Gatsiou A; Sopova K; Klein J; Biedermann T; Stellos K; Ziemssen F
Ophthalmologica; 2015; 234(4):195-210. PubMed ID: 26305017
[TBL] [Abstract][Full Text] [Related]
12. Flow cytometric analysis of the platelet surface area and surface density of glycoprotein IIb-IIIa of unactivated human platelets of various sizes.
Leytin V; Shapiro H; Novikov I; Radnay J
Biochem Biophys Res Commun; 1996 Sep; 226(1):94-100. PubMed ID: 8806597
[TBL] [Abstract][Full Text] [Related]
13. Influence of aflibercept on platelet activation profile.
Sobolewska B; Golenko J; Poeschel S; Grimmel C; Gatsiou A; Sopova K; Biedermann T; Schenke-Layland K; Stellos K; Ziemssen F
Exp Eye Res; 2018 Oct; 175():166-172. PubMed ID: 29908884
[TBL] [Abstract][Full Text] [Related]
14. Relationship between changes in platelet reactivity and changes in platelet receptor expression induced by physical exercise.
Aurigemma C; Fattorossi A; Sestito A; Sgueglia GA; Farnetti S; Buzzonetti A; Infusino F; Landolfi R; Scambia G; Crea F; Lanza GA
Thromb Res; 2007; 120(6):901-9. PubMed ID: 17337041
[TBL] [Abstract][Full Text] [Related]
15. Activation and shedding of platelet glycoprotein IIb/IIIa under non-physiological shear stress.
Chen Z; Mondal NK; Ding J; Koenig SC; Slaughter MS; Griffith BP; Wu ZJ
Mol Cell Biochem; 2015 Nov; 409(1-2):93-101. PubMed ID: 26160282
[TBL] [Abstract][Full Text] [Related]
16. Incomplete inhibition of platelet aggregation and glycoprotein IIb-IIIa receptor blockade by abciximab: importance of internal pool of glycoprotein IIb-IIIa receptors.
Gawaz M; Ruf A; Pogatsa-Murray G; Dickfeld T; Rüdiger S; Taubitz W; Fischer J; Müller I; Meier D; Patscheke H; Schömig A
Thromb Haemost; 2000 Jun; 83(6):915-22. PubMed ID: 10896249
[TBL] [Abstract][Full Text] [Related]
17. A major role for CD62P/CD15s interaction in leukocyte margination during hemodialysis.
Stuard S; Carreno MP; Poignet JL; Albertazzi A; Haeffner-Cavaillon N
Kidney Int; 1995 Jul; 48(1):93-102. PubMed ID: 7564097
[TBL] [Abstract][Full Text] [Related]
18. The basis examination of leukocyte-platelet aggregates with CD45 gating as a novel platelet activation marker.
Nagasawa A; Matsuno K; Tamura S; Hayasaka K; Shimizu C; Moriyama T
Int J Lab Hematol; 2013 Oct; 35(5):534-41. PubMed ID: 23356866
[TBL] [Abstract][Full Text] [Related]
19. Regulation of CD40L (CD154) and CD62P (p-selectin) surface expression upon GPIIb-IIIa blockade of platelets from stable coronary artery disease patients.
Chandler AB; Earhart AD; Speich HE; Kueter TJ; Hansen J; White MM; Jennings LK
Thromb Res; 2010 Jan; 125(1):44-52. PubMed ID: 19487018
[TBL] [Abstract][Full Text] [Related]
20. Roles of Mac-1 and glycoprotein IIb/IIIa integrins in leukocyte-platelet aggregate formation: stabilization by Mac-1 and inhibition by GpIIb/IIIa blockers.
Patko Z; Csaszar A; Acsady G; Peter K; Schwarz M
Platelets; 2012; 23(5):368-75. PubMed ID: 22671289
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
